The registration for this event has passed. Check back soon for content you missed, post-event updates, as well as recommendations for future events you may be interested in.
Details
Join Illumina at BioTechX Europe 2026 to discover how together we can solve critical research challenges in drug discovery by leveraging large-scale genomic and multiomic datasets, evidence-based AI guidance, and advanced analytics. Learn how researchers can generate relevant evidence throughout the drug development lifecycle, to deepen understanding of complex biology, uncover meaningful insights, and make informed research decisions.
Register to watch Illumina's panel discussion. The recording will be available soon.
Register to watch Illumina's panel discussion. The recording will be available soon.
Panel Discussion:
Gaining a competitive advantage in drug discovery through linked, multi-dimensional data at scale
Tuesday, 6 October 2026 | 17:25-18:05
Actionability of data in drug discovery depends on the completeness of underlying datasets and the analytical infrastructure to generate meaningful insights. This is amplified in the era of AI-driven interpretation, where models are only as powerful as the data they're trained on. As drug discovery teams adopt rapidly advancing approaches like machine learning for target identification, virtual cell modeling, and multiomic profiling, access to large-scale, diverse datasets with complete metadata has become a strategic imperative. This panel examines how hyperscale initiatives like the Alliance for Genomic Discovery (350,000+ whole genomes and 50,000+ linked proteomes) and the Illumina Billion Cell Atlas are providing the foundational data infrastructure for next-generation drug discovery. Panelists will bring expertise spanning functional genomics, machine learning, ADME, antibody developability and more to discuss what it takes to build AI-ready datasets, the importance and challenges of integrating across diverse datasets and infrastructures, and how both proprietary and pre-competitive collaboration are impacting today’s R&D landscape.
Moderator
Andrew Harris
Senior Director, Business Development, Corporate & Venture Development, Illumina
Speakers
 |
|
 |
Dr. Vinay Pawar Novo Nordisk A/S, Director Digital Science External Partnership, |
 |
Dr. Ivan Kryukov Bayer Bayer, Senior Genomic Data Scientist |
 |
Dinesh Divakaran, PhD, MBA Illumina, Global Head of Data Business Development |
Software demos
Interested in a free trial of Illumina analysis software? Visit Booth 422 for a live demonstration of bioinformatics solutions for multiomic analysis, population-scale projects, rare disease research, and more.
Connect with our team
Visit Booth 422 to discuss your research challenges, data strategies, and opportunities for collaboration with Illumina experts.
Meet the Illumina Team
Visit Booth 422 to learn how Illumina is helping pharmaceutical and biotechnology organizations:
- Accelerate drug discovery research
- Generate deeper biological insights from complex datasets
- Support AI-guided scientific exploration
- Improve collaboration across research teams
- Build cumulative knowledge across studies and programs
- Maximize the value of large-scale genomic and multiomic research investments
- Learn about free-trials of Illumina Connected Multiomics and other BioInsight products
- Date & Time
- 6 Oct 2026 – 8 Oct 2026
- Location
- Messe, Basel
- Switzerland
- Europe
- Topic
- Drug discovery & development, Population genomics